A Phase IIA Trial Assessing the Tolerability of Abemaciclib in Combination with Endocrine Therapy in Patients Age 70 and Older with Hormone Receptor Positive Metastatic Breast Cancer Who Have Progressed on or After Prior CDK 4/6 Inhibition
ENROLLING
Trial ID:
NCT04305834 Protocol # :
21-707
Phase
II
Disease Sites
Breast
Principal Investigator
Freedman, Rachel, A
Site Research Nurses
Campbell, Margaret
Ficociello, Samantha
Kasparian, Elizabeth
Kuhlman, Rachel
Orechia, Meghan
Patel, Nikita
Roche, Kathleen, A.
Rutter, Morgan
Trial Description
Call 877-DF-TRIAL (877-338-7425) to learn more about this clinical trial, protocol #21-707
21-707